The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor-informed ctDNA as an objective marker for postoperative residual disease in epithelial ovarian cancer.
 
Valentina Paspalj
No Relationships to Disclose
 
Christoph Grimm
Consulting or Advisory Role - AstraZeneca; Eisai Europe; GlaxoSmithKline; MSD Oncology
Speakers' Bureau - AstraZeneca; Eisai Europe; GlaxoSmithKline; Merck
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; GlaxoSmithKline
 
Magdalena Postl
No Relationships to Disclose
 
Christina Viktoria Tauber
Research Funding - SAGA Diagnostics (research material for study purposes only) (Inst)
 
Nuria Segui
No Relationships to Disclose
 
Christian Brueffer
Employment - SAGA Diagnostics
Stock and Other Ownership Interests - SAGA Diagnostics
Consulting or Advisory Role - OmiCure (Inst)
Patents, Royalties, Other Intellectual Property - Methods related to structural variant analysis in cancer. (Inst)
Other Relationship - InSilico Consulting AB
 
Miguel Alcaide
Employment - SAGA DIAGNOSTICS
Stock and Other Ownership Interests - SAGA DIAGNOSTICS
Patents, Royalties, Other Intellectual Property - Methods for ctDNA monitoring
 
Lucia Oton
No Relationships to Disclose
 
Yilun Chen
No Relationships to Disclose
 
Lao H. Saal
Employment - SAGA Diagnostics
Leadership - SAGA Diagnostics
Stock and Other Ownership Interests - SAGA Diagnostics
Research Funding - SAGA Diagnostics
Patents, Royalties, Other Intellectual Property - SAGA Diagnostics
 
Gerda Hofstetter
No Relationships to Disclose
 
Leonhard Muellauer
No Relationships to Disclose
 
Mirjana Kessler
Research Funding - Gilead Sciences
Patents, Royalties, Other Intellectual Property - Ovarian cancer culture medium-patent
 
Fabian Trillsch
Honoraria - AstraZeneca; Eisai; MSD Oncology; Tesaro/GSK
Consulting or Advisory Role - AstraZeneca; Eisai Germany; Immunogen; MSD Oncology; Tesaro/GSK
Research Funding - AstraZeneca (Inst); SAGA Diagnostics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Immunogen; Tesaro/GSK